Antikoagulation (Leitlinien)
1K+
Downloads
Everyone
info
About this app
Bleeding due to platelet aggregation inhibitors and other anti-clotting medication is a common problem in clinical practice. This application is intended and give a quick overview of interventions required time intervals. How long a certain anticoagulant should be paused in order to be able to do a spinal anesthesia? How long must I wait until I followed the Anticoagulant Therapy on again lead? Which anticoagulants, renal function should be considered?
In addition, a simplified PT / INR conversion table is contained.
This application is not meant to be scientific work. You should only present contents of the subject. The information contained in this application are based on the 3.überarbeitete recommendation of the German Society of Anesthesiology and Intensive Care Medicine (DGAI) on "Neuraxial regional anesthesia and thromboembolism / undertreatment medication (class S1) (http://www.awmf.org/leitlinien /detail/ll/001-005.html). All information is subject of accuracy or completeness. Use of this application is at your own risk. decisions in the clinical setting should be based on an individual and possibly interdisciplinary risk-benefit analysis. suggestions or criticism I take against you. Use it to vote button!
Disclaimer
This application was developed for training purposes.
The information in this application must be strictly checked before use by the attending physician and verified. The author of this work does not assume any responsibility for the accuracy and timeliness of the data presented. Any kind of liability claims arising from the use of this application will be rejected. If they do not agree, they can not install the application.
In addition, a simplified PT / INR conversion table is contained.
This application is not meant to be scientific work. You should only present contents of the subject. The information contained in this application are based on the 3.überarbeitete recommendation of the German Society of Anesthesiology and Intensive Care Medicine (DGAI) on "Neuraxial regional anesthesia and thromboembolism / undertreatment medication (class S1) (http://www.awmf.org/leitlinien /detail/ll/001-005.html). All information is subject of accuracy or completeness. Use of this application is at your own risk. decisions in the clinical setting should be based on an individual and possibly interdisciplinary risk-benefit analysis. suggestions or criticism I take against you. Use it to vote button!
Disclaimer
This application was developed for training purposes.
The information in this application must be strictly checked before use by the attending physician and verified. The author of this work does not assume any responsibility for the accuracy and timeliness of the data presented. Any kind of liability claims arising from the use of this application will be rejected. If they do not agree, they can not install the application.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region and age The developer provided this information and may update it over time.
This app may share these data types with third parties
Device or other IDs
No data collected
Learn more about how developers declare collection
Data isn’t encrypted
Data can’t be deleted
What's new
- Touch Input verbessert.
- Analytics verbessert.
- Analytics verbessert.
